Beez Biotech provides medical disposables and biological protocols that improve sperm selection for assisted reproductive technologies. Their products aim to enhance the quality and success rates of procedures like IVF and ICSI.
Funding
Funding not disclosed
Founders
Product
Problem
In assisted reproductive technologies (ART) like IVF and ICSI, selecting high-quality sperm is crucial for fertilization success, but current methods often lack precision and efficiency. The low success rate of MAR (medically assisted reproduction) leaves many facing infertility challenges with limited options.
Solution
Beez Biotech provides advanced medical disposables and biological protocols to improve sperm selection in ART. Their microfluidic-based technology, including the upcoming EVA technology, enhances sperm quality selection, aiming to significantly increase the success rates of procedures like IVF and ICSI. By focusing on quality gamete selection and leveraging cutting-edge innovations, Beez Biotech strives to support MAR professionals and parents-to-be at every step, improving the chances of healthy childbirth. They also offer 3D printing-based rapid fluidic devices prototyping to accelerate microfluidics prototyping process.
Target Audience
The primary customers are MAR (medically assisted reproduction) professionals, IVF clinics, and research labs focused on improving fertility treatment outcomes.
Features
- Microfluidic sperm selection technology for enhanced sperm quality.
- Biological protocols designed to improve sperm selection for ART.
- 3D printing-based rapid prototyping of microfluidic devices.
- CAD and CFD tools for microchannel simulation, design, and fabrication.
- Customized solutions for microfluidics projects, from design to device assembly.